Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide

Parkins, C.S., Holder, A.L., Hill, S.A. et al. (2 more authors) (2000) Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide. British Journal of Cancer, 83 (6). pp. 811-816. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Parkins, C.S.
  • Holder, A.L.
  • Hill, S.A.
  • Chaplin, D.J.
  • Tozer, G.M.
Copyright, Publisher and Additional Information: © 2000, Cancer Research Campaign. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: combretastatin A-4 phosphate; vasculature; nitric oxide; neutrophil; SOLID TUMOR-THERAPY; ISCHEMIA-REPERFUSION INJURY; DEPENDENT MECHANISM; NORMAL-TISSUES; MURINE TUMORS; TUBULIN; MYELOPEROXIDASE; AGENTS; TOXICITY; RADICALS
Dates:
  • Published: September 2000
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 18 May 2017 09:23
Last Modified: 18 May 2017 09:23
Published Version: https://doi.org/10.1054/bjoc.2000.1361
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1054/bjoc.2000.1361

Share / Export

Statistics